The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Gastroenterology & Hepatology in conversation with

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(50)

Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes

Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes

Hannes Hagström discusses a study investigating the feasibility of screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes. Read the full article: https://www.t...

10 Tammi 202521min

Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn’s disease small bowel strictures

Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn’s disease small bowel strictures

Cathy Lu (University of Calgary) discusses a consensus statement on the use of intestinal ultrasound for assessing and monitoring small bowel strictures in Crohn's disease. Read the full article: htt...

12 Joulu 202411min

Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis

Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis

Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis. Read th...

6 Marras 202414min

Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease

Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease

Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and mai...

1 Marras 202434min

Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma prev...

31 Heinä 202418min

Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy. Read the full ar...

1 Heinä 202425min

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS. ...

17 Touko 202423min

Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn’s disease

Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn’s disease

Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease. Read the full article: https://www.thelanc...

7 Touko 202419min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
aamukahvilla
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
rss-pitaisko-erota
meditaatiot-suomeksi
psykopodiaa-podcast
terapiassa
rss-kuumilla-aalloilla
katilon-kahvitunti
voi-hyvin-meditaatiot-2
rss-pt-paahtio
rss-sanelunpurku-podcast
paritellen
rss-duodecim-lehti
fitnesskuplassa
rss-uplevel-by-sonja-hannus
rss-kehtaanko-kysya-podcast-aideille
rss-mighty-finland-podcast
selviytyjat-tarinoita-elamasta